ANDA 76886, held by Dr Reddys. Fosphenytoin Sodium.
As of Nov 16, 2026, ANDA 76886 (Fosphenytoin Sodium), held by Dr Reddys, was first approved by FDA on Aug 6, 2007, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 6, 2007 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Fosphenytoin SodiumEQ 50MG PHENYTOIN NA/ML · injectable;injection | Fosphenytoin Sodium | Discontinued |
| Dec 17, 2020 | Supplement 11Labeling · Standard review | Approved | None posted |
| Dec 17, 2020 | Supplement 10Labeling · Standard review | Approved | None posted |
| Dec 17, 2020 | Supplement 9Labeling · Standard review | Approved | None posted |
| Aug 6, 2007 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters